Esperion Therapeutics, Inc.

ESPRDelisted Jul 13, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001434868

SEC filings (opens in a new tab)

Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.

Q4 2023 vs. Q3 2023

How the institutions holding Esperion Therapeutics, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of ESPR: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Of which not filed for Q4 2023	Q4 2023	Change
Holders	123	1	132	+10
Shares	77.3M	60.0K	71.9M	−5.29M (−6.8%)
Value	$75.9M	$58.8K	$215.3M	+$139.5M (+184.0%)

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Esperion Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to ESPR in Q4 2023
Institution	Shares	Value	% of portfolio
Armistice Capital, LLC	3,200,000	$9.57M	0.25%
D. E. Shaw & Co., Inc.	1,213,203	$3.63M	0.01%
Whitefort Capital Management, LP	885,522	$2.65M	1.69%
Woodline Partners LP	290,382	$868.2K	0.01%
Walleye Capital LLC	214,000	$639.9K	0.01%
Marex Group plc	150,000	$448.5K	0.02%
683 Capital Management, LLC	134,689	$402.7K	0.04%
Susquehanna Portfolio Strategies, LLC	116,246	$347.6K	0.01%
Diametric Capital, LP	88,170	$263.6K	0.16%
Boston Private Wealth LLC	60,554	$181.1K	0.00%
Mirabella Financial Services LLP	42,200	$126.2K	0.02%
Balyasny Asset Management LLC	37,188	$111.2K	0.00%
Eaton Financial Holdings Company, LLC	34,030	$101.8K	0.02%
Caption Management, LLC	31,600	$94.5K	0.01%
Kingsview Wealth Management, LLC	31,500	$94.2K	0.00%
Prelude Capital Management, LLC	29,791	$89.1K	0.01%
Y-Intercept (Hong Kong) Ltd	27,269	$81.5K	0.01%
Jump Financial, LLC	25,823	$77.2K	0.00%
Azimuth Capital Investment Management LLC	22,000	$65.8K	0.00%
Marathon Trading Investment Management LLC	21,000	$62.8K	0.01%
Point72 Asia (Singapore) Pte. Ltd.	20,200	$60.4K	0.01%
Mesirow Financial Investment Management, Inc.	20,000	$59.8K	0.00%
Foundations Investment Advisors, LLC	20,000	$41.4K	0.00%
Captrust Financial Advisors	10,050	$30.1K	0.00%
Private Portfolio Partners LLC	10,000	$29.9K	0.01%
O'Dell Group, LLC	4,500	$13.5K	0.00%
Headlands Technologies LLC	3,208	$9.59K	0.00%
Wetzel Investment Advisors, Inc.	1,000	$3.00K	0.00%
City State Bank	200	$1.00K	0.00%
Advisory Services Network, LLC	62	$185	0.00%

Sold out (20)

Institutions that held Esperion Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of ESPR in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
XTX Topco Ltd	519,129	$508.7K
Group One Trading, L.P.	310,778	$304.6K
AQR Capital Management LLC	202,985	$198.9K
Virtu Financial LLC	181,597	$178.0K
Acadian Asset Management LLC	136,346	$131.0K
Tudor Investment Corp Et Al	72,525	$71.1K
Two Sigma Securities, LLC	36,678	$35.9K
Mariner, LLC	26,130	$25.6K
Bayesian Capital Management, LP	17,600	$17.2K
SEI Investments Co	13,633	$13.4K
Warberg Asset Management LLC	13,000	$12.8K
Parallax Volatility Advisers, L.P.	10,967	$10.7K
Simplex Trading, LLC	10,618	$10.0K
Quantbot Technologies LP	6,122	$6.00K
China Universal Asset Management Co., Ltd.	2,748	$2.69K
Cary Street Partner Investment Advisory LLC	550	$539
Trust Co of Vermont	300	$294
Creative Planning	100	$98
Jefferies Financial Group Inc.	65	$64
Harbour Investments, Inc.	7	$7

Not filed for Q4 2023 yet (1)

Institutions that held Esperion Therapeutics, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ESPR in Q3 2023 that haven't filed for Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Jacob Asset Management of New York LLC	60,000	$58.8K